No corticosteroid regrows pattern hair, and hydrocortisone has no regrowth evidence anywhere. Steroids only help by calming the immune attack in alopecia areata or the inflammation in scarring alopecia.
People reach for a tube of hydrocortisone for almost everything, so it is a fair question: can a steroid cream regrow your hair? We went through the clinical and preclinical literature, ranked it by data quality, and the answer is cleaner than the internet makes it sound.
The short answer: No corticosteroid has been shown to regrow hair in pattern baldness, and hydrocortisone has no regrowth evidence in any condition. Where steroids do bring hair back, it is in alopecia areata, an autoimmune disease, and even there they are calling off an immune attack rather than stimulating the follicle, so the regrowth usually relapses when you stop (Delamere 2008). In scarring alopecias like lichen planopilaris and frontal fibrosing alopecia, steroids halt the inflammation and preserve the hair you still have, but they do not regrow scar. In the lab, glucocorticoids do the opposite of grow hair: they push follicles into rest (Choi 2021). And chronic potent steroids on the scalp thin the skin.
Not in the way most people mean. A corticosteroid is an anti-inflammatory drug, not a follicle stimulant. It has a real, measurable effect on hair only in diseases where inflammation or an immune attack is the thing removing the hair. Take that attack away and the hair that was being shed can return. That is a genuine effect, but it is fundamentally different from what minoxidil or finasteride do in pattern hair loss, where the follicle itself is coaxed to grow.
Here is the whole evidence base, ranked by how good the data is.
| Condition | Best evidence | Steroid + route | Result | Data quality |
|---|---|---|---|---|
| Alopecia areata | Tosti 2006 (RCT) | Clobetasol 0.05% foam | Regrowth on 89% of treated vs 11% of placebo scalp halves | Strongest, but small (n=34) |
| Alopecia areata | Lenane 2014 (RCT) | Clobetasol vs hydrocortisone 1% | Clobetasol beat hydrocortisone, ~85% vs ~33% reaching 50% regrowth (P<0.001) | Good (n=41, pediatric) |
| Alopecia areata | Abell 1973 (controlled) | Intralesional triamcinolone | ~61% regrew vs ~7% of saline-injected controls | Moderate (within-patient) |
| Alopecia areata | Kar 2005 (RCT) | Oral pulse prednisolone | Modest benefit over placebo, not durable | Good design, weak effect |
| Alopecia areata | Delamere 2008 (Cochrane) | All routes | No intervention, steroids included, showed lasting benefit over placebo | Highest (systematic review) |
| Scarring (FFA/LPP) | Vano-Galvan 2014 | Topical/intralesional steroid | Stabilizes and halts progression, does not regrow scar | Retrospective (n=355) |
| Scarring (FFA eyebrows) | Donovan 2010 | Intralesional triamcinolone | 10/11 regrew eyebrows (early, non-scarred follicles) | Case series |
| Androgenetic alopecia | None | Any | No regrowth evidence | No credible data |
| Any condition, hydrocortisone alone | None | Topical hydrocortisone | No regrowth evidence anywhere | None |
Two patterns jump out. Every real regrowth result is in an inflammatory or autoimmune disease, and the strength of the steroid matters: the potent and superpotent molecules (clobetasol, triamcinolone) do the work, while weak hydrocortisone is the arm that loses.
No. There is no study, in any hair-loss condition, showing that hydrocortisone regrows hair on its own. Hydrocortisone is a Class VII agent, the weakest tier of topical steroid, which is exactly why it is sold over the counter. In the one head-to-head trial that included it, hydrocortisone 1% cream was the deliberately weak comparator against clobetasol in children with alopecia areata, and it lost: only about a third of the hydrocortisone group reached 50% regrowth versus about 85% on clobetasol, with clobetasol superior at nearly every timepoint (Lenane 2014).
The one place you will see a hydrocortisone-and-hair claim is a 26-man example pairing minoxidil 3% with hydrocortisone 2.5%. That is a US patent example, not a peer-reviewed controlled trial, and any hair growth in it is attributable to the minoxidil. It is not evidence that hydrocortisone grows hair.
Yes, but it is immune suppression, not follicle stimulation, and it tends to relapse. Alopecia areata is an autoimmune disease in which the immune system attacks otherwise healthy follicles and forces them to shed. The follicle is not destroyed, so if you shut the attack down, the hair can grow back. Potent topical clobetasol regrew hair on 89% of treated scalp halves versus 11% of placebo halves in a controlled trial (Tosti 2006), and intralesional triamcinolone injections have a long track record, with roughly 61% regrowth versus 7% of saline-injected control sites in an early controlled study (Abell 1973).
The honest caveats are large. These trials are small, alopecia areata has a high spontaneous remission rate that inflates uncontrolled studies, extensive disease responds worst, and relapse when you stop is the rule rather than the exception. The Cochrane systematic review concluded that no treatment, corticosteroids included, had shown a significant long-term hair-growth benefit over placebo (Delamere 2008). Steroids buy time and cosmetic regrowth in alopecia areata; they do not cure it.
Yes, but by halting damage, not by regrowing hair. In primary scarring (cicatricial) alopecias, inflammation destroys the follicle's stem-cell region and replaces it with scar. Once that has happened, the follicle is gone for good. Corticosteroids, usually topical clobetasol or intralesional triamcinolone, are used to suppress the inflammation at the active edges and stop the disease from spreading. In the largest frontal fibrosing alopecia review, steroids and 5-alpha-reductase inhibitors were associated with stabilization of the disease (Vano-Galvan 2014). The only setting where genuine regrowth is documented is early, not-yet-scarred follicles, classically the eyebrows in frontal fibrosing alopecia (Donovan 2010).
So your instinct is right: steroids are worth using in scarring alopecia, but the goal is to keep the hair you still have, not to regrow what has already scarred over. The evidence here is also weak in the formal sense, made up almost entirely of retrospective series and expert consensus, with no placebo-controlled trials.
No. Androgenetic alopecia, the common male and female pattern hair loss, is a non-inflammatory, hormone-driven miniaturization of the follicle. There is no immune attack to call off and no active inflammation to cool, so a steroid has nothing to act on. No corticosteroid, by any route, has credible evidence of regrowing hair in pattern baldness. Steroids show up in this setting only as an anti-inflammatory add-on when someone also has seborrheic dermatitis or scalp irritation, which is treating the second condition, not the baldness.
They slow it down. This is the part that should reframe the whole question. In laboratory models, glucocorticoids and cortisol suppress the dermal papilla (the follicle's control center) and push follicles out of their growth phase into rest. In mice, corticosterone inhibits hair-follicle stem-cell activation and keeps follicles in prolonged telogen, acting through the dermal papilla (Choi 2021, published in Nature). In cultured human dermal papilla cells, glucocorticoids cut proliferation and growth factors like VEGF and HGF (Choi 2013). The follicle even runs its own local stress-hormone system, and activating it drives a catagen-like regression (Ito 2005).
This is the same biology behind stress-related shedding: the cortisol your body releases under stress is a brake on hair growth, not an accelerator. It is a strong reason not to think of a steroid as a hair tonic.
Chronic use of potent topical steroids carries real, well-documented harms: skin thinning (atrophy), spider veins (telangiectasia), stretch marks, and a rebound flare when you stop (topical steroid withdrawal). Extensive or potent scalp use can suppress the body's own cortisol axis. Systemic steroids can actually trigger hair shedding through telogen effluvium (Zhang 2023). There is a paradoxical effect where potent topical steroids occasionally cause extra fine hair at the application site, but that is a localized, cosmetically unwanted side effect that comes bundled with atrophy, not a way to regrow a bald scalp. For everyday pattern hair loss, the risk-to-benefit math on casual steroid use is clearly unfavorable.
If your question is "will hydrocortisone or another steroid regrow my hair," the evidence says no for pattern baldness and no for hydrocortisone in general. Steroids are a real tool in the dermatologist's kit, but for the right disease and the right reason: to call off an autoimmune attack in alopecia areata, and to stop the burn in scarring alopecia so you keep what you have. They do not stimulate the follicle, the follicle biology actually runs the other way, and casual use on the scalp risks thinning the skin. Growing hair and calling off an attack that is removing hair are two very different things, and only one of them is what a steroid does.
No. There is no evidence that hydrocortisone regrows hair in any condition. It is the weakest class of topical steroid, and in the one trial that tested it head to head it was beaten by clobetasol in alopecia areata (Lenane 2014). Any hair growth people attribute to a hydrocortisone-and-minoxidil product comes from the minoxidil.
Only specific kinds. In alopecia areata (autoimmune) and scarring alopecias like lichen planopilaris and frontal fibrosing alopecia, corticosteroids reduce the immune attack or inflammation and can bring back or preserve hair. They do nothing for common pattern baldness, which is not an inflammatory disease.
In alopecia areata, intralesional triamcinolone injections can regrow patches, with roughly 61% regrowth versus 7% in saline-injected controls in an early study (Abell 1973). In scarring alopecia the same injections mainly halt progression. They are not used for pattern baldness, and repeated injections can thin and dent the skin.
Because they treat two different problems. Alopecia areata is an immune attack on a living follicle, so suppressing the immune system lets the hair return. Pattern baldness is a hormone-driven shrinking of the follicle with no immune attack for a steroid to switch off.
Yes. Systemic corticosteroids can trigger telogen effluvium, a diffuse temporary shedding (Zhang 2023), and the stress hormone cortisol pushes follicles into their resting phase (Choi 2021). Chronic potent topical steroids also thin the skin, which does the hair no favors.
This article is for educational purposes only and is not medical advice. Corticosteroids for hair and scalp conditions are prescription decisions (aside from low-strength over-the-counter hydrocortisone) that should be made with a licensed clinician. Alopecia areata and scarring alopecias are distinct diseases from androgenetic alopecia and require a proper diagnosis. Nothing here is a claim that any product treats, cures, or prevents any condition. Talk to a dermatologist before using a topical steroid on your scalp.